MétaCan
Menu
Back to cohort
Record W4287377570 · doi:10.1111/pcmr.13058

Landscape of mutations in early stage primary cutaneous melanoma: An <scp>InterMEL</scp> study

2022· article· en· W4287377570 on OpenAlexaff
Li Luo, Ronglai Shen, Arshi Arora, Irene Orlow, Klaus J. Busam, Cecilia Lezcano, Tim K. Lee, Eva Hernando, Ivan Gorlov, Christopher I. Amos, Marc S. Ernstoff, Venkatraman Seshan, Anne Ε. Cust, James S. Wilmott, Richard A. Scolyer, Graham J. Mann, Eduardo Nagore, Pauline Funchain, Jennifer S. Ko, Peter Ngo, Sharon N. Edmiston, Kathleen Conway, Paul B. Googe, David W. Ollila, Jeffrey E. Lee, Shenying Fang, Judy R. Rees, Cheryl L. Thompson, Meg R. Gerstenblith, Marcus Bosenberg, Bonnie Gould Rothberg, Iman Osman, Yvonne M. Saenger, Adam Z. Reynolds, Matthew Schwartz, Tawny W. Boyce, Sheri L. Holmen, Elise K. Brunsgaard, Paul N. Bogner, Pei Fen Kuan, Charles L. Wiggins, Nancy E. Thomas, Colin B. Begg, Marianne Berwick

Bibliographic record

VenuePigment Cell & Melanoma Research · 2022
Typearticle
Languageen
FieldMedicine
TopicCutaneous Melanoma Detection and Management
Canadian institutionsBC Cancer Agency
FundersNational Center for Advancing Translational SciencesMemorial Sloan-Kettering Cancer CenterNational Institute of Environmental Health SciencesLineberger Comprehensive Cancer Center, University of North Carolina at Chapel HillNational Institute of General Medical SciencesNational Health and Medical Research CouncilUniversity of Texas MD Anderson Cancer CenterRoswell Park Alliance Foundation, Roswell Park Cancer InstituteChar and Chuck Fowler Family FoundationNational Cancer InstituteNational Institutes of HealthCleveland Foundation
KeywordsNeuroblastoma RAS viral oncogene homologCDKN2AMelanomaPerineural invasionGNAQCancer researchMedicineStage (stratigraphy)PathologyBiologyMutationKRASInternal medicineCancerGeneGeneticsColorectal cancer

Abstract

fetched live from OpenAlex

It is unclear why some melanomas aggressively metastasize while others remain indolent. Available studies employing multi-omic profiling of melanomas are based on large primary or metastatic tumors. We examine the genomic landscape of early-stage melanomas diagnosed prior to the modern era of immunological treatments. Untreated cases with Stage II/III cutaneous melanoma were identified from institutions throughout the United States, Australia and Spain. FFPE tumor sections were profiled for mutation, methylation and microRNAs. Preliminary results from mutation profiling and clinical pathologic correlates show the distribution of four driver mutation sub-types: 31% BRAF; 18% NRAS; 21% NF1; 26% Triple Wild Type. BRAF mutant tumors had younger age at diagnosis, more associated nevi, more tumor infiltrating lymphocytes, and fewer thick tumors although at generally more advanced stage. NF1 mutant tumors were frequent on the head/neck in older patients with severe solar elastosis, thicker tumors but in earlier stages. Triple Wild Type tumors were predominantly male, frequently on the leg, with more perineural invasion. Mutations in TERT, TP53, CDKN2A and ARID2 were observed often, with TP53 mutations occurring particularly frequently in the NF1 sub-type. The InterMEL study will provide the most extensive multi-omic profiling of early-stage melanoma to date. Initial results demonstrate a nuanced understanding of the mutational and clinicopathological landscape of these early-stage tumors.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Insufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.219
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0020.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0010.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.037
GPT teacher head0.320
Teacher spread0.283 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations21
Published2022
Admission routes1
Has abstractyes

Explore more

Same venuePigment Cell & Melanoma ResearchSame topicCutaneous Melanoma Detection and ManagementFrench-language works237,207